Authors: K. Gazdíková; P. Korecká 1; V. Špringer 1; F. Gazdík Authors‘ workplace: Oddelenie klinickej imunológie a farmakoterapie Ústavu preventívnej a klinickej medicíny, Bratislava 1Katedra organizácie a riadenia farmácie Farmaceutickej fakulty Univerzity Komenského, Bratislava Published in: Čes. slov. Farm., 2002; , 287-291 Category:
Treatment by dialyzing represents an important contribution to the therapy of nephropathicpatients. On the other hand, besides high financial costs it is not possible to forger significant socialand psychic consequences of this therapy. The present paper aimed at a pharmacoeconomic evaluationof the costs of conservative treatment of nephropathic patients. The secondary aim was tocompare the costs of conservative treatment in patients with markedly limited renal functions,creatinine clearance (Ccr < 0.4 ml/s), with those in patients with only slightly and medium-reducedrenal functions (Ccr 0.4–1 ml/s). Health documentation from three nephrological out-patientsurgeries was used to evaluate the results, the criterion for the selection of patients being a nephrologicaldiagnosis with Ccr below 1 ml/s. The group comprised 102 patients aged 21–84 years (averageage being 63.99 years), including 56 females (54.9 %) and 46 males (45.1 %). According to the stageof renal disease, they were divided into two groups. The patients with slightly and medium-reducedrenal functions (Ccr 0.4–1.0 ml/s) represented nearly three quarters, whereas the patients withmarkedly reduced renal functions (Ccr
Key words: pharmacoeconomics – nephropathy – antihpyertensives – hypolipidemics – essentialaminoacids
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
